Stay updated on T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.

Latest updates to the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check18 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study evaluating trastuzumab deruxtecan for HER2-positive metastatic breast cancer, while adding new identifiers and descriptions related to the study's design and drug information.SummaryDifference13%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 16, 2024.SummaryDifference0.3%
- Check39 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous estimated update date of December 16, 2024.SummaryDifference0.2%
- Check68 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check91 days agoChange DetectedThe web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, along with a notice about potential performance issues due to heavy traffic.SummaryDifference0.8%
Stay in the know with updates to T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.